Voleon Capital Management LP Invests $282,000 in Aspen Aerogels, Inc. $ASPN

Key Points

• Voleon Capital Management purchased 44,060 shares of Aspen Aerogels, valued at approximately $282,000, during the first quarter, owning about 0.05% of the company by the end of that period.
• Other hedge funds also increased their stakes in Aspen Aerogels, with Allspring Global Investments boosting its position by 96.2%, and institutional investors collectively owning 97.64% of the company's stock.
• Analysts rated Aspen Aerogels with a consensus of "Moderate Buy," while the stock's price target has varied from $10.00 to $19.50, reflecting differing outlooks on the company's market performance.

Voleon Capital Management LP bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 44,060 shares of the construction company's stock, valued at approximately $282,000. Voleon Capital Management LP owned 0.05% of Aspen Aerogels as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its holdings in Aspen Aerogels by 96.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 299,311 shares of the construction company's stock valued at $1,901,000 after purchasing an additional 146,794 shares during the period. Janney Montgomery Scott LLC acquired a new position in Aspen Aerogels during the first quarter valued at approximately $681,000. Concurrent Investment Advisors LLC acquired a new position in Aspen Aerogels during the first quarter valued at approximately $109,000. BNP Paribas Financial Markets lifted its position in Aspen Aerogels by 645.4% during the fourth quarter. BNP Paribas Financial Markets now owns 135,584 shares of the construction company's stock valued at $1,611,000 after buying an additional 117,395 shares in the last quarter. Finally, Exchange Traded Concepts LLC lifted its position in Aspen Aerogels by 460.4% during the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after buying an additional 6,109 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Aspen Aerogels Stock Down 2.9%

ASPN traded down $0.20 during trading on Friday, hitting $6.60. The company had a trading volume of 1,341,668 shares, compared to its average volume of 1,438,317. The company has a market cap of $543.58 million, a PE ratio of -1.73 and a beta of 2.65. The business has a 50-day moving average of $7.12 and a 200-day moving average of $6.48. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The firm's quarterly revenue was down 33.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insiders Place Their Bets

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and lifted their price target for the company from $7.00 to $16.00 in a research report on Monday, August 11th. Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average target price of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.